Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000808527 | SCV000948637 | benign | Duchenne muscular dystrophy | 2024-10-14 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003145160 | SCV003829550 | uncertain significance | not provided | 2020-02-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004994029 | SCV005566447 | likely benign | Cardiovascular phenotype | 2024-09-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001835972 | SCV002093438 | uncertain significance | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2019-02-06 | no assertion criteria provided | clinical testing |